WAY Price Prediction Next Week
Stock Price Prediction for WAY
Based on the analysis of technical indicators and recent news sentiment, here is the prediction for the stock price of WAY for the next trading week:
Technical Analysis:
- Current Price: $35.93 (as of 2025-03-17)
- RSI (14-period): 39.27 (below 50, indicating potential overselling)
- MACD: -1.19 (bearish signal line crossover)
- Stochastic Oscillator: 12.33 (%K) and 13.65 (%D) (oversold territory)
- Fibonacci Levels:
- Pivot Point: $39.57
- Support 1 (S1): $35.74
- Resistance 1 (R1): $43.40
News Sentiment:
- Insider Trading: Significant insider selling activity, with T. Craig Bridge selling 26% of his holdings, signaling potential lack of confidence.
- Analyst Upgrades: Truist initiated coverage with a Buy rating and $45 price target, while other firms like Canaccord, BofA, and Barclays raised their price targets.
- Options Activity: High volume in put options, particularly the $37.50 strike expiring March 21, indicating bearish sentiment.
Prediction:
Given the bearish technical indicators and mixed news sentiment, the stock is expected to face resistance at $37.50 and support at $35.74. The Fibonacci levels suggest a potential decline below $35.74 if the stock breaks below the current support level.
Predicted Price for Next Trading Week: $34.50
Recommendation: Sell
WAY Similar Chart Price Prediction
The price of WAY is predicted to go up -3.77%, based on the high correlation periods with HAFC. The similarity of these two price pattern on the periods is 96.45%.
WAY
HAFC
Down: -3.77%Similarity: 96.45%
WAY Revenue Forecast
WAY EPS Forecast
WAY FAQs
What is WAY revenue forecast for next quarter？
What is WAY eps forecast for next quarter？
WAY Analyst's Forecast
Jailendra Singh
Truist Securities
Strong Buy
2025-03-14
Price Target
$45
Upside
+23.39%
Truist initiated coverage of Waystar with a Buy rating and $45 price target. The company is positioned to benefit from the evolution that the healthcare payments workflow is currently undergoing where providers are increasingly looking for automated software solutions to reduce administrative burden and improve efficiency, the analyst tells investors in a research note. The firm believes Waystar has approached its 2025 guidance conservatively, and would not be surprised to see another year of "beat and raise" quarters.
Richard Close
Canaccord Genuity
Strong Buy
2025-02-24
Price Target
$42 → $50
Upside
+18.85%
Stephanie Davis
Barclays
Buy
2025-02-19
Price Target
$42 → $50
Upside
+14%
